Newsroom

Sorted by: Latest

-

Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences

OSLO, Norway & BOSTON--(BUSINESS WIRE)--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout...
-

Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trus...
-

Polestar Sets the Date for Reporting the Second Quarter Select and Half-Year 2026 Results

GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) expects to publish the second quarter select and half-year 2026 unaudited financial results on 3 September 2026, before market open. Management will host a conference call at 14:00 Central European Time (08:00 US Eastern Time) the same day, accessible via the Polestar Investor Relations website. To register and join the call, please use this link https://edge.media-server.com/mmc/p/czg84qrx/ or follow the instructions available under...
-

Great Hill Partners Announces Strategic Investment in Aurenity

BOSTON--(BUSINESS WIRE)--Great Hill Partners (“Great Hill”), a private equity firm that invests in high-growth, disruptive companies, today announced a strategic investment in Aurenity (the “Company”), a technology-enabled excess & surplus (“E&S”) managing general agent (“MGA”). Agman, Aurenity's founding investor, and the Company’s management team will retain a significant portion of their equity stakes in connection with the transaction. Financial terms were not disclosed. Great Hill'...
-

United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that company executives will provide overviews and updates during fireside chat sessions at four upcoming investor conferences. Martine Rothblatt, Chairperson and Chief Executive Officer, will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026, from 11:00 a.m. to 11:35 a.m., EST. Martine Rothblatt, Chairperson and Ch...
-

Filigran Adds Attack Chaining to OpenAEV for Autonomous Penetration Testing and Red Teaming

PARIS--(BUSINESS WIRE)--Filigran, the European open-source threat management company, today announced Attack Chaining, an attack-path validation capability that automates penetration testing and red teaming with OpenAEV, the company's adversarial exposure validation product. The capability arrives today as part of OpenAEV v3.Adversaries do not run techniques in isolation. They chain them: reconnaissance surfaces a target, a credential dump yields a password, that password opens the next machine,...
-

Rockwell Automation to Present at Morgan Stanley 14th Annual Laguna Conference

MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE: ROK) Chairman & CEO, Blake Moret, and SVP, Intelligent Devices, Tessa Myers, will present at the Morgan Stanley 14th Annual Laguna Conference on Wednesday, Sept. 16, in Dana Point, California. The fireside chat will be webcast beginning at approximately 8:30 a.m. PDT and will be available on the Rockwell Automation Investor Relations website at www.rockwellautomation.com/en-us/investors.html. About Rockwell Automation Rockwell Aut...
-

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced completion of the last patient visit for the planned Phase 1 safety and efficacy analysis of prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus (SLE) with or without lupus nephritis (LN)...
-

YCharts Makes Inc. 5000 List 10th Consecutive Year

CHICAGO--(BUSINESS WIRE)--YCharts, a leading investment research and client engagement platform trusted by thousands of financial professionals across North America, has been named to the Inc. 5000 list of America's fastest-growing private companies for the 10th consecutive year. The recognition caps a period of steady expansion for the company, which has also been named a 2026 Wealth Management “Wealthies” Award finalist and is set to speak at and attend the Future Proof Festival in Huntington...
-

Influential Canadian Leaders Unite in Support of Quality Early Childhood Education

MONTREAL--(BUSINESS WIRE)--22 influential Canadians have signed an open letter calling on leaders from all sectors to join them in supporting early childhood education as a nation-building investment in Canada’s future. The letter highlights the broad and lasting benefits that quality early learning and childcare services contribute to Canada. These benefits begin with children developing stronger cognitive, social, and physical skills that improve school readiness; extend to families by enabli...